To evaluate anterior scleral thickness (AST) in patients with ocular hypertension (OHT) using anterior segment-optical coherence tomography (AS-OCT).
Methods
Forty-two eyes of 21 patients with OHT and 40 eyes of 40 healthy participants were included in this cross-sectional study. AST was measured at the level of the scleral spur (SS)(AST-0), 1000 µm posterior of the SS (AST-1), and 2000 µm posterior of the SS (AST-2) in the nasal and temporal quadrants using AS-OCT.
Results
The mean ages were 58.2 ± 12 (27–78) for OHT group; 54.2 ± 9.8 (21–70) years for control group (p > 0.05). The mean nasal AST-0, AST-1 and AST-2 were 647 ± 25.7 (592–689), 490.7 ± 16.4 (453–526), 513.6 ± 19.2 (481–554) µm in OHT group; 701.7 ± 44.9 (605–785), 521.7 ± 33.4 (433–579), 535.5 ± 33.3 (449–599) µm in control group, respectively. The mean temporal AST-0, AST-1 and AST-2 were 667 ± 28.9 (620–723), 495.9 ± 18.7 (459–545), 509.3 ± 24 (430–596) µm in OHT group; 718.1 ± 45.9 (618–796), 525.3 ± 29.8 (456–583), 533.4 ± 41 (450–611) µm in control group, respectively. Mean ASTs measured at all three points in OHT group were significantly thinner than in control group in both nasal and temporal quadrants (p < 0.05).
Conclusion
We found that the scleral thickness was significantly thinner in OHT patients. It is still unknown whether the sclera plays a role in the OHT pathogenesis by affecting the biomechanical response of the globe to IOP elevation. Or conversely, sclera may undergo structural changes secondary to long-term IOP elevation in OHT. Although there are hints about the relationship between sclera and IOP, the mechanisms are still unclear.
AlpoganOTokluMDikmenNT. Correlation between structural and functional tests in primary open-angle glaucoma. Eur Eye Res2021; 1: 136–142.
2.
GordonMOKassMAGroupOHTS. The ocular hypertension treatment study: design and baseline description of the participants. Arch Ophthalmol1999; 117: 573–583.
3.
GordonMOBeiserJABrandtJD, et al.The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol2002; 120: 714–720.
4.
KassMAGordonMOGaoF, et al.Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol2010; 128: 276.
5.
KassMAHeuerDKHigginbothamEJ, et al.The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol2002; 120: 701–730.
6.
JonasJBWangNWangYX, et al.Ocular hypertension: general characteristics and estimated cerebrospinal fluid pressure. The Beijing eye study 2011. PLoS One2014; 9: e100533.
7.
BuckhurstHDGilmartinBCubbidgeRP, et al.Measurement of scleral thickness in humans using anterior segment optical coherent tomography. PLoS One2015; 10: e0132902–e0132902.
8.
Lopilly ParkHYLeeNY, et al.Measurement of scleral thickness using swept-source optical coherence tomography in patients with open-angle glaucoma and myopia. Am J Ophthalmol2014; 157: 876–884.
9.
YanXLiMChenZ, et al.The anterior scleral thickness in eyes with primary open-angle glaucoma. Graefe’s Arch Clin Exp Ophthalmol2022; 260: 1601–1610.
10.
YooCEomYSSuhY-W, et al.Central corneal thickness and anterior scleral thickness in Korean patients with open-angle glaucoma: an anterior segment optical coherence tomography study. J Glaucoma2011; 20: 95–99.
11.
Mohamed-NoorJBochmannFSiddiquiMAR, et al.Correlation between corneal and scleral thickness in glaucoma. J Glaucoma2009; 18: 32–36.
12.
EilaghiAFlanaganJGSimmonsCA, et al.Effects of scleral stiffness properties on optic nerve head biomechanics. Ann Biomed Eng2010; 38: 1586–1592.
13.
NormanREFlanaganJGRauschSMK, et al.Dimensions of the human sclera: thickness measurement and regional changes with axial length. Exp Eye Res2010; 90: 277–284.
14.
BurgoyneCFDownsJCBellezzaAJ, et al.The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res2005; 24: 39–73.
15.
QuigleyHAFlowerRWAddicksEM, et al.The mechanism of optic nerve damage in experimental acute intraocular pressure elevation. Invest Ophthalmol Vis Sci1980; 19: 505–517.
16.
TunTAWangXManiB, et al.Effect of age and glaucoma on anterior peripapillary sclera shape. Invest Ophthalmol Vis Sci2018; 59: 2028.
17.
KorkmazIDegirmenciCSelverOB, et al.Evaluation of scleral thickness in patients with fuchs endothelial dystrophy. Graefes Arch Clin Exp Ophthalmol2023; 261: 2883–2889.
18.
KorkmazIEsen BarisMGuven YilmazS, et al.Effect of cycloplegia on anterior segment structures and scleral thickness in emmetropic eyes. J Ocul Pharmacol Ther2023; 39: 699–704.
19.
JonasJBWangNYangD, et al.Facts and myths of cerebrospinal fluid pressure for the physiology of the eye. Prog Retin Eye Res2015; 46: 67–83.
20.
WangYXJonasJBWangN, et al.Intraocular pressure and estimated cerebrospinal fluid pressure. The Beijing eye study 2011. PLoS One2014; 9: e104267.
21.
BooteCSigalIAGrytzR, et al.Scleral structure and biomechanics. Prog Retin Eye Res2020; 74: 100773.
22.
KaushikSPandavS. An overview of current understanding in ocular hypertension. J Curr Glaucoma Pract2011; 5: 12–13.
23.
SigalIAFlanaganJGEthierCR. Factors influencing optic nerve head biomechanics. Invest Ophthalmol Vis Sci2005; 46: 4189–4199.
BrandtJDBeiserJAKassMA, et al.Central corneal thickness in the ocular hypertension treatment study (OHTS). Ophthalmology2001; 108: 1779–1788.
26.
MalgazSMayaliHErdoganM, et al.Comparison of the reliability and repeatability of central corneal thickness measurements from four different non-contact devices. Eur Eye Res2021; 1: 143–149.
27.
SinghRPGoldbergIGrahamSL, et al.Central corneal thickness, tonometry, and ocular dimensions in glaucoma and ocular hypertension. J Glaucoma2001; 10: 206–210.
28.
Tüzün SayınDAltanCSolmazB, et al.Comparison of corneal biomechanical properties in primary open angle glaucoma, normal-tension glaucoma, and ocular hypertension. Eur Eye Res2021; 1: 115–121.
29.
YacoubSSessumsQLiB, et al.Ocular hypertension-induced changes in the anterior segment of cynomolgus monkeys. Invest Ophthalmol Vis Sci2013; 54: 1975.
30.
ArgusWA. Ocular hypertension and central corneal thickness. Ophthalmology1995; 102: 1810–1812.
31.
ÖzyolPKaracaIPalamarM. The influence of light condition on anterior segment parameters with pentacam in healthy subjects. Eur Eye Res2021; 1: 13–16.
32.
WishartPKBatterburyM. Ocular hypertension: correlation of anterior chamber angle width and risk of progression to glaucoma. Eye1992; 6: 248–256.
33.
WangYCaoH. Corneal and scleral biomechanics in ophthalmic diseases: an updated review. Med Nov Technol Devices2022; 15: 100140.
34.
NémethJ. The posterior coats of the eye in glaucoma. An echobiometric study. Graefe’s Arch Clin Exp Ophthalmol1990; 228: 33–35.
35.
NguyenCConeFENguyenTD, et al.Studies of scleral biomechanical behavior related to susceptibility for retinal ganglion cell loss in experimental mouse glaucoma. Invest Ophthalmol Vis Sci2013; 54: 1767–1780.
36.
PijankaJKSpangMTSorensenT, et al.Depth-dependent changes in collagen organization in the human peripapillary sclera. PLoS One2015; 10: e0118648.
37.
DownsJCEnsorMEBellezzaAJ, et al.Posterior scleral thickness in perfusion-fixed nor normal and early-glaucoma monkey eyes. Invest Ophthalmol Vis Sci2001; 42: 3202–3208.
38.
KimJAKimTWLeeEJ, et al.Comparison of Lamina cribrosa morphology in eyes with ocular hypertension and normal-tension glaucoma. Invest Ophthalmol Vis Sci2020; 61: 4.
39.
VurgeseSPanda-JonasSJonasJB. Scleral thickness in human eyes. PLoS One2012; 7: e29692.
40.
ReadSAlonso-CaneiroDVincentS, et al.Anterior eye tissue morphology: scleral and conjunctival thickness in children and young adults. Sci Rep2016; 6: 33796.
